![Koji Kitami](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Koji Kitami
Directeur/Membre du Conseil chez Site Quality Co., Ltd.
Profil
Koji Kitami is currently the Representative Director at Site Quality Co., Ltd.
and a Director at MediBIC Pharma.
Previously, he held the position of President & Representative Director at MediBIC Group and MediBIC KK.
He was also a Director at Animal Stemcell KK and an Executive Officer & Manager-Strategic Planning at MediBIC Group from 2000 to 2007.
Postes actifs de Koji Kitami
Sociétés | Poste | Début |
---|---|---|
Site Quality Co., Ltd.
![]() Site Quality Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Site Quality Co., Ltd. provides consulting services to medical institutions. It offers informed consent acquisition assistance, patient schedule administration, hospital data collection management, time monitoring, case report form preparation support, document creation assistance, and clinical research coordination. The company was founded in November 2003 and is headquartered in Hachioji, Japan. | Directeur/Membre du Conseil | 01/03/2013 |
MediBIC Pharma | Directeur/Membre du Conseil | - |
Anciens postes connus de Koji Kitami
Sociétés | Poste | Fin |
---|---|---|
MEDIBIC GROUP | Corporate Officer/Principal | 01/11/2007 |
Animal Stemcell KK
![]() Animal Stemcell KK BiotechnologyHealth Technology Part of MediBIC Group, Animal Stemcell KK engages in research and development, and production of animal stem cells and regenerative medicine. The company is based in Koganei, Japan. Animal Stemcell KK was acquired by MediBIC Group from Resort & Medical Co., Ltd. on October 08, 2013 for $3.02 million. | Directeur/Membre du Conseil | - |
MediBIC KK
![]() MediBIC KK Miscellaneous Commercial ServicesCommercial Services Part of MediBIC Group, MediBIC KK develops genomic medicines. The company is based in Tokyo, Japan. The Japanese company was founded by Yasuhiro Hashimoto. | President | - |
MEDIBIC GROUP | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
MediBIC Group
![]() MediBIC Group Miscellaneous Commercial ServicesCommercial Services MediBIC Group is a holding company which engages in the biotechnology industry that specializes in pharmacogenomics (PGx). It engages in analysis and reporting service on healthcare and drug development; information processing, services and consulting in biotech field; computer system design and development; drug & diagnostic product development; and business consulting services. The firm’s services also include sample banking and management service, GLP-compliant Gene Profiling Service, genetic testing service, licensing, cell culture systems and consumable sale. The company was founded on February 17, 2000 and is headquartered in Tokyo, Japan. | Commercial Services |
Site Quality Co., Ltd.
![]() Site Quality Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Site Quality Co., Ltd. provides consulting services to medical institutions. It offers informed consent acquisition assistance, patient schedule administration, hospital data collection management, time monitoring, case report form preparation support, document creation assistance, and clinical research coordination. The company was founded in November 2003 and is headquartered in Hachioji, Japan. | Commercial Services |
MediBIC Pharma | |
MediBIC KK
![]() MediBIC KK Miscellaneous Commercial ServicesCommercial Services Part of MediBIC Group, MediBIC KK develops genomic medicines. The company is based in Tokyo, Japan. The Japanese company was founded by Yasuhiro Hashimoto. | Commercial Services |
Animal Stemcell KK
![]() Animal Stemcell KK BiotechnologyHealth Technology Part of MediBIC Group, Animal Stemcell KK engages in research and development, and production of animal stem cells and regenerative medicine. The company is based in Koganei, Japan. Animal Stemcell KK was acquired by MediBIC Group from Resort & Medical Co., Ltd. on October 08, 2013 for $3.02 million. | Health Technology |